Related Experiment Video

Updated: Jun 12, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Selective inhibition of proteins regulating CDK/cyclin complexes: strategy against cancer--a review

P Sarita Rajender1, D Ramasree, K Bhargavi

  • 1Department of Chemistry, Nizam College, Basheerbagh, Hyderabad, Andhra Pradesh, India.

Journal of Receptor and Signal Transduction Research
|June 22, 2010
PubMed

Insights

Targeting cell cycle regulators like cyclin C and CDKN1C offers a promising strategy for cancer prevention. Computational methods can identify critical targets in cell cycle signaling for future cancer research.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cancer prevention is a global health priority, yet achieving this goal remains challenging.
  • Cyclin-dependent kinase (CDK)/cyclin complexes are crucial regulators of the cell cycle, conserved across evolution.
  • Uncontrolled cell division in cancer cells highlights CDKs/cyclins as critical targets.

Purpose of the Study:

  • To identify key proteins involved in regulating CDK/cyclin complexes at the G(0)-S phase transition.
  • To explore the potential of targeting these regulators for cancer research and prevention.

Main Methods:

  • Identification of specific proteins: cyclin C, cyclin D2, CDKN1C, and Growth Arrest and DNA Damage (GADD45alpha).
  • Focus on proteins regulating CDK/cyclin complexes in early cell cycle stages.
  • Application of modern computational techniques for target identification.

Main Results:

  • Cyclin C, cyclin D2, CDKN1C, and GADD45alpha identified as significant regulators of CDK/cyclin complexes.
  • These proteins play a major role in the G(0) to S phase transition of the cell cycle.
  • Computational approaches are highlighted as valuable tools for discovering cancer targets.

Conclusions:

  • Targeting specific CDK/cyclin regulators like cyclin C, cyclin D2, CDKN1C, and GADD45alpha presents a promising avenue for cancer prevention.
  • Modern computational techniques are essential for identifying and validating critical targets in cell cycle signaling pathways.
  • This research provides a foundation for developing novel therapeutic strategies against cancer.

More Related Videos

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...